Day 1 - Thursday, 28 June 2018
Topics
Meeting category
Date(s)
28 Jun 2018 - 30 Jun 2018
Location
Hong Kong,
China
Organizer
Titanium Level Support
Sponsor logos
APACC 2018
Related Enduring Materials
Enduring Materials
-
Professor David Cooper Tribute Eulogy
Presentation
Plenairy session 1: Strategies to end AIDS in the Asia-Pacific -
David Cooper Memorial Lecture: Current effort to control the epidemic in the region
Parallel session 1: Future of ART in LMICs -
Treatment regimens for the public health approach – do we need to change?
Parallel session 2: Evolving epidemiology -
Derivation of population mixing patterns from virus sequence data and their impacts on the modelling of HIV epidemics in MSM
Transmitted drug resistance and impact on long-term clinical outcomes in the VMVN clinical trial in Hanoi, Vietnam
Treatment outcome and drug resistance mutations among patients on LPVr-containing second-line antiretroviral therapy in Vietnam (Not available)
Junko Tanuma
#3
Chemsex: prevalence, characteristics and associated risk profiles of men who have sex with men in South Australia: a cross-sectional cohort study
Day 2 - Friday, 29 June 2018
Planairy session 2: Management of advanced HIV disease -
Current gaps between policy and practice in the Asia Pacific region
Challenges in the management of advanced HIV disease from the clinical perspective
Parallel session 3: Social media and mHealth -
Social media to increase HIV testing uptake in China
Parallel session 4: Co-infections and complications -
Human papillomavirus prevalence and behavioral risk factors among HIV-Infected men in central Taiwan
Malignancies in adults living with HIV in Asia (Not available)
Awachana Jiamsakul
#6
Drivers for mental health issues among young and old HIVinfected individuals and opportunities for intervention
Asymptomatic talaromyces mareffei infection is associated with HIV mortality (Not yet available)
Thu Nguyen Thi Mai
#8
Outcome of HCV treatment by direct acting antiretroviral (DAAs) among HCV/HIV co-infections in Vietnam
Parallel session 5: Poster discussion on MSM and TG sexual risk in Asia -
Identifying MSM-competent physicians in China: A national online cross-sectional survey among physicians who see male HIV/STD patients
Pre-exposure prophylaxis (PrEP) service in a South East Asian university hospital – one year experience
Treatment for anorectal Chlamydia trachomatis infection with azithromycin 1g single dose in mem who have sex with men w/o HIV infection
Reducing condomless sex among Chinese Men Who Have Sex with Men through repeated exposure to online videos: results from an online cohort study
The pattern of risk compensation in MSM enrolled in a pilot PrEP project
Voices of the hidden: Implementation of the people living with HIV stigma index in Taiwan
Parallel session 6: Poster discussion on strategies to improve HIV outcomes in Asia -
Cost-effectiveness of Dolutegravir in HIV-1 treatment-naïve patients in China
DTG versus LPV/r in second line (DAWNING): outcomes by WHO-recommended NRTI backbone
Assessing the efficacy of Lopinavir /ritonavir based preferred and alternative second-line regimens on HIV-infected patients : a meta-analysis as a key evidence support for WHO recommendations
Routine versus targeted viral load strategy among patients starting ART in Hanoi, Vietnam
Replicating the success: Using an HIV model of peer driven intervention (PDI+) to increase TB new case detection in Cambodia
Optimal timing of antiretroviral therapy for HIV-infected patients with cryptococcal meningitis: A systematic review and meta-analysis
Parallel session 7: Optimizing clinical management of long-term complications -
Improving tolerability by optimizing ART
Addressing long-term complications to improve health outcomes in HIV
Parallel session 8: Prevention and linkage to treatment -
Feasibility and outcome of rapid initiation of antiretroviral treatment among newly-diagnosed HIV-positive patients at a tertiary center in Taiwan
Impact of initiation of combination antiretroviral therapy according to the WHO recommendations on the survival of HIV-positive patients in Taiwan
Renal and liver function changes among post-exposure prophylaxis clients at the Thai Red Cross Anonymous Clinic in Bangkok
Changes in creatinine and estimated glomerular filtration rate during the first 12-month period of pre-exposure prophylaxis among PrEP-30 clients at the Thai Red Cross anonymous clinic
Debate: IPT should be implemented for all HIV patients in the Asia-Pacific -
Thuy Le, MD, DPhil
Pro debater: IPT should be implemented for all HIV patients in the Asia-Pacific
Acceptability and experiences of assisted and unassisted oral fluid testing among men who have sex with men and transgender women in Thailand: Implications to roll out and scale-up
Con debater: IPT should be implemented for all HIV patientsin the Asia-Pacific
Duke University; Oxford University Clinical Research Unit, United States / Vietnam
Day 3 - Saturday, 30 June 2018
Parallel session 9: Panel discussion: Key populations-led health service models -
KPLHS for HIV testing and PrEP in Vietnam
Parallel session 10: Immune interventions to control HIV -
Introduction to immunology - What clinicians need to know
Broadly neutralizing antibodies for treatment and prevention of HIV-1
Plenairy session 3: Viral Hepatitis -
What’s new in Hepatitis B treatment & diagnostics
Capacity building sessions -
Thuy Le, MD, DPhil
How to do a systematic review
Matthew Law, BA (Hons), MSc, PhD
The Kirby Institute, Australia
Research methodology
Getting involved in clinical research: from clinical trials to sub-studies
Duke University; Oxford University Clinical Research Unit, United States / Vietnam
Overview
Welcome
The very successful 3rd Asia Pacific AIDS & Co-infections Conference (APACC) took place from 28 to 30 June 2018 in Hong Kong.
Organizing Committee would like to thank all invited speakers and participants for their contribution to this conference!
We would like to thank our supporters ViiV Healthcare, Gilead Sciences, Mylan, MSD, AbbVie and Hong Kong Toursim Board for making this event possible.
General Information
Unique Features
- A program with a special focus on the needs in Asia and the Pacific
- A true scientific platform for regional clinicians and clinical researchers to present their data
- Insights into important clinical developments and updates on ongoing and new trials
- Capacity building workshops and career development sessions for young professionals
- A great opportunity to network with your colleagues throughout Asia
- A true scientific platform for regional clinicians and clinical researchers to present their data
- Insights into important clinical developments and updates on ongoing and new trials
- Capacity building workshops and career development sessions for young professionals
- A great opportunity to network with your colleagues throughout Asia
Meeting Objectives
This meeting aims to:
- Promote dissemination and successful translation of new knowledge regarding HIV and co-infections while facilitating a neutral environment
- Foster new and lasting cross-disciplinary partnerships and collaborations between researchers in HIV, hepatitis, tuberculosis, policymakers, and NGOs, among others, in order to improve knowledge sharing, with the end goal of improving healthspan within the rapidly growing HIV/AIDS population
- Attract, showcase, and maintain new, early career, and underrepresented investigators to this multidisciplinary area of research and to translate novel findings into clinical practice
- Promote dissemination and successful translation of new knowledge regarding HIV and co-infections while facilitating a neutral environment
- Foster new and lasting cross-disciplinary partnerships and collaborations between researchers in HIV, hepatitis, tuberculosis, policymakers, and NGOs, among others, in order to improve knowledge sharing, with the end goal of improving healthspan within the rapidly growing HIV/AIDS population
- Attract, showcase, and maintain new, early career, and underrepresented investigators to this multidisciplinary area of research and to translate novel findings into clinical practice
Learning Objectives
After participating in this activity, participants will be able to:
- Describe the major achievements and challenges in antiviral therapy for HIV and/or hepatitis-positive patients in the Asia Pacific region
- Identify improved treatment options for their patients
- Initiate (research) collaborations to further improve the level of knowledge on clinical management in the Asia Pacific region
- Use gained knowledge to make/advocate for appropriate adjustments to policies in public, institutional, and private settings
- Describe the major achievements and challenges in antiviral therapy for HIV and/or hepatitis-positive patients in the Asia Pacific region
- Identify improved treatment options for their patients
- Initiate (research) collaborations to further improve the level of knowledge on clinical management in the Asia Pacific region
- Use gained knowledge to make/advocate for appropriate adjustments to policies in public, institutional, and private settings
Practical Information
Disclaimer
This conference is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this conference, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this conference. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the conference.
Liability and Insurance
By registering for the conference participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official conference sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the conference is finished, provided the speaker has given permission to do so.
Support
Language
Related Programs
